Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer
Authors:
Open Access
- 26 September 2023
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-10
Abstract
Though palbociclib, a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor has been approved for treating breast cancer, two major clinical challenges remain: (i) Triple-negative breast cancer (TNBC) appears to be more resistant to palbociclib, and (ii) Palbociclib-induced senescence-associated secretory phenotype (SASP) has a pro-tumorigenic function. Here we report that combining palbociclib with the STAT3 inhibitor nifuroxazide uncouples SASP production from senescence-associated cell cycle exit. Moreover, we identified nifuroxazide as a CDK2 inhibitor that synergistically promotes palbociclib-induced growth arrest and senescence in TNBC cells. In vitro, the combination of nifuroxazide with palbociclib further inhibited the TNBC cell proliferation and enhanced palbociclib-induced cell cycle arrest and senescence. The modulation of palbociclib-induced SASP by nifuroxazide was associated with the reduction of phosphorylated-STAT3. Nifuroxazide also blocks SASP-dependent cancer cell migration. Furthermore, thermal shift assay and molecular docking of nifuroxazide with STAT3 and CDK2 revealed that it binds to their active sites and acts as a potent dual inhibitor. In vivo, the combination of nifuroxazide with palbociclib suppressed 4T1 tumor growth and lung metastasis. Our data suggest that nifuroxazide enhances the anticancer effects of palbociclib in TNBC by uncoupling SASP production from senescence-associated cell cycle exit and inhibiting CDK2 to promote tumor senescence.Keywords
Funding Information
- Fundo para o Desenvolvimento das Ciências e da Tecnologia (0081/2021/A2)
- Universidade de Macau (SP2023-00001-FSCPO)
This publication has 39 references indexed in Scilit:
- JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old ageProceedings of the National Academy of Sciences, 2015
- 4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory ResponsesPLOS ONE, 2015
- Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer modelCell Death & Disease, 2015
- The cellular thermal shift assay for evaluating drug target interactions in cellsNature Protocols, 2014
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer SubtypesJournal of Clinical Oncology, 2012
- SwissDock, a protein-small molecule docking web service based on EADock DSSNucleic Acids Research, 2011
- An Important Role for CDK2 in G1 to S Checkpoint Activation and DNA Damage Response in Human Embryonic Stem CellsStem Cells, 2011
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay MethodCancer Research, 2010
- STATs in cancer inflammation and immunity: a leading role for STAT3Nature Reviews Cancer, 2009
- Regulation of the G1 phase of the mammalian cell cycleCell Research, 2000